Williams led development to achieve FDA clearance.
2 reports, 2 independent
Updated Sep 20
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Williams led development to achieve FDA clearance.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BriaCell sought IND clearance from the FDA.1 source
Williams led development resulting in FDA clearance.1 source
Keep exploring
The entities involved
Related events
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Arthur Caplan questioned the FDA regarding the status of clinical trials in 2006.
- FDA placed a clinical hold on the drug application submitted by Bright Minds Biosciences Inc.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- Vera Therapeutics and the FDA agreed to shift the assessment of a clinical study.
Coverage
Newest first; wire copies grouped- digitaljournal.com
- GlobeNewswireDr. Michelle LeRoux Williams Earns Washington Business Journal’s Medical Device Innovator Award GAITHERSBURG, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Compa